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Oral mucosal Langerhans cells (LC) are likely to play important roles in host defense
against infection by human cytomegalovirus (CMV). We previously showed that
in vitro-differentiated immature LC (iLC) populations contain smaller amounts of infected
cells but produce higher yields than mature LC (mLC) cultures, obtained by iLC
stimulation with fetal bovine serum (FBS), CD40 ligand (CD40L) and lipopolysaccharide
(LPS). Here, we sought to determine if exposure to select stimuli can improve LC
permissiveness to infection, if specific components of the mLC cocktail are responsible
for lowering viral yields, if this is due to defects in progeny production or release, and if
these restrictions are also effective against reactivated virus. None of the stimuli tested
extended the proportion of infected cells to 100%, suggesting that the block to infection
onset cannot be fully removed. While CD40L and FBS exerted positive effects on viral
progeny production per cell, stimulation with LPS alone or in combination with CD40L
was detrimental. Reductions in viral titers were not due to defects in progeny release, and
the permissive or restrictive intracellular environment established upon exposure to each
stimulus appeared to act in a somewhat similar way toward lytic and latent infections.
Keywords: langerhans cells, dendritic cells, cytomegalovirus, host defense, infection restrictions
INTRODUCTION
Langerhans-type dendritic cells (LC) are the only type of innate immune cells found in the epithelial
layer of human oral mucosae, where they provide an initial line of defense against invading
microorganisms (Barrett et al., 1996; Allam et al., 2003, 2006, 2008; Cutler and Jotwani, 2006;
Novak et al., 2008). Acquisition of human cytomegalovirus (CMV), a source of serious disease
in newborns, transplant recipients, and AIDS patients, normally occurs early in life by contact
between contaminated bodily fluids, such as urine and saliva, and host oronasal mucosae. Limited
replication within mucosal cells at the time of infection is followed by viral spread to the bone
marrow, where latency is established (Pass, 2001; Britt, 2007; Mocarski et al., 2007). Intermittent
bouts of reactivation then release virus back in the urine and saliva, thus promoting viral spread to
new hosts.
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Being present at densities of 20–80 cells/mm2 in the outermost
layers of the oral mucosa (Cruchley et al., 1989, 1994; Lasisi
et al., 2013; Upadhyay et al., 2013; Omine et al., 2015), LC
are among the first cell types to encounter CMV during entry,
together with epithelial cells. Their differentiation from CD34+
hematopoietic progenitors (Iijima et al., 2007), a well-known
site of CMV latency (Minton et al., 1994; Mendelson et al.,
1996; Zhuravskaya et al., 1997; Slobedman and Mocarski, 1999;
Khaiboullina et al., 2004), was also shown to be associated with
viral genome maintenance (Reeves et al., 2005a,b; Reeves and
Sinclair, 2010), and reactivation (Reeves et al., 2005a,b; Reeves
and Sinclair, 2010; Huang et al., 2012).
Although mucosal LC are conventionally considered
immature, their actual maturation status is likely to be more
heterogeneous, as the oral mucosa is normally colonized by a
variety of microorganisms whose identity and pathogenicity
depend on the health and hygiene of the host. Local contacts
with infiltrating CD4+ and CD8+ lymphocytes expressing
the CD40 ligand (CD40L), with bacterial products such as
lipopolysaccharide (LPS) or with pro-inflammatory cytokines
such as interleukin-1β (IL-1β), tumor necrosis factor α (TNF-α),
and prostaglandin E2 (PGE2) can indeed stimulate mucosal LC
maturation and migration (Yavuzyilmaz et al., 1995; Heasman
et al., 1998; Orima et al., 1999; Loro et al., 2001; Orozco et al.,
2006).
We previously showed that infection initiates in only a
small fraction of in vitro-differentiated immature LC (iLC), as
compared to mature LC (mLC) obtained by iLC stimulation with
granulocyte-macrophage colony-stimulating factor (GM-CSF),
fetal bovine serum (FBS), LPS and CD40L (Lauron et al., 2014;
Coronel et al., 2015). Despite this and quite surprisingly, iLC
produced higher amounts of viral progeny than mLC (Coronel
et al., 2015), suggesting that CMV replication in these cells
undergoes at least two blocks: one acting early and restricting
infection onset to only specific cells within the population, and
one acting later, reducing viral yields in mLC. Exposure of iLC
differentiated from latently infected progenitors to the mLC
cocktail also failed to enhance viral DNA replication and progeny
production, suggesting that signaling by FBS, CD40L, and LPS in
combination does not trigger robust CMV reactivation (Coronel
et al., 2015).
In this work, we sought to determine: (1) if select stimuli can
increase the proportion of LC that initiate infection by relieving
the initial block; (2) if these stimuli also increase viral yields; (3)
if the magnitude of progeny production can be predicted from
the number of viral antigen+ cells detected at infection onset;
(4) if populations containing large amounts of infected cells are
also the most efficient at producing progeny; (5) if mLC’s low
yields are due to restrictions in progeny production or release; (6)
which specific component(s) of the mLC cocktail is responsible
for increasing the proportion of infected cells and for reducing
viral yields, and (7) if similar restrictions also apply to progeny
produced following viral reactivation from latency.
We show that iLC stimulation with the mLC cocktail, with
pro-inflammatory cytokines or with CD40L, but not with FBS
or LPS, increases the proportion of infected cells. Populations
exposed to pro-inflammatory cytokines or CD40L also produced
yields similar to those of iLC, while treatment with FBS, LPS,
or the mLC cocktail reduced progeny amounts to different
extents. A linear correlation was observed between the number
of antigen+ cells present at infection onset and the amount of
progeny produced at peak times, with the notable exception
of mLC cultures. As the proportion of infected cells changed
over time with different kinetics in each population, an inverse
correlation was detected between the amount of progeny
produced per cell and the total number of antigen+ cells present
at late times post-infection, suggesting that conditions which
support prolonged viral protein expressionmay reduce the ability
of each infected cell to produce virus.
Populations matured using the mLC cocktail remained the
only ones to display large(r) amounts of infected cells but
extremely low yields, a phenotype possibly ascribable to the
opposing effects of exposure to CD40L, which increased the
proportion of infected cells and viral yields, and to LPS,
which reduced both parameters. All LC populations contained
approximately twice as much cell-associated than cell-free virus,
suggesting that defects in progeny release are unlikely to be
the source of mLC’s low yields. By contrast, the number of
cell-associated particles per infected cell ranged from ∼0.2 in
mLC to ∼6 in FBS cultures, implying the existence of a severe
block to progeny production in mLC populations. With the
notable exception of pro-inflammatory cytokines, none of the
tested stimuli increased the extent of viral reactivation beyond
that observed in iLC cultures, indicating that the intracellular
environments that restrict lytic viral replication also constrain
viral reactivation. Together, these data highlight the remarkable
functional plasticity of LC: instead of being strongly polarized
toward either a fully permissive or a fully resistant phenotype, LC
responses to CMV infection and reactivation follow a continuum
whereby the strength and extent of the restrictions imposed vary
depending on the nature and combination of the stimuli received.
MATERIALS AND METHODS
Cells and Virus
Immature LC populations were derived from cord blood CD34+
hematopoietic progenitor cells (STEMCELL Technologies Inc.,
Vancouver, Canada, six different donors) as previously described
(Lauron et al., 2014; Coronel et al., 2015). LC activation was
induced by exposure to 1500 IU/ml of GM-CSF and 10% FBS
(US origin, Gibco, Life Technologies, South San Francisco, CA),
or 1500 IU/ml of GM-CSF and 200 ng/ml of CD40L (Peprotech,
Rocky Hill, NJ), or 1500 IU/ml of GM-CSF and 250 ng/ml of
LPS (Sigma-Aldrich, St. Louis, MO), or 1500 IU/ml of GM-
CSF, 200 ng/ml of CD40L, and 250 ng/ml of LPS, or 1500 IU/ml
of GM-CSF, 10% FBS, 200 ng/ml of CD40L and 250 ng/ml of
LPS, or 125 U/ml of TNF-α, 400 IU/ml of IL-1β, 1000 IU/ml
of IL-6 and 5 nmol/ml of PGE2 (all from BioVision, Inc.,
Milpitas, CA), or 1500 IU/ml of GM-CSF, 10% FBS, 200 ng/ml
of CD40L, 250 ng/ml of LPS, 125U/ml of TNF-α, 400 IU/ml of
IL-1β, 1000 IU/ml of IL-6, and 5 nmol/ml of PGE2. CMV strain
TB40/E was propagated on human foreskin fibroblasts (HFF) as
previously described (Hertel et al., 2003).
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Cell Infection
Immature LC harvested at day 8 post-differentiation were
counted and re-plated in iLC or in each activation medium
for 2 days prior to exposure to TB40/E virions at a calculated
multiplicity of infection (MOI) of 10 for 4 h. Cells were then
washed twice and re-plated in iLC or in each activation medium
for 10 days. For reactivation studies, CD34+ cells were thawed
and immediately exposed to TB40/E virions at a calculated MOI
of 10 for 4 h, prior to washing and plating in iLC medium. At day
8, iLC were harvested, counted, and re-plated in iLC or in each
activation medium for 10 days. Latently-infected LC harvested at
day 2, 4, and 8 were counted and added at a density of 104–105
per 5 × 105 confluent HFF in single wells of six well-plates. At
day 8 of co-culture, plates were stained with Giemsa and plaques
were counted.
Immunofluorescence Staining Analyses
Cytospin preparations were fixed in 1% formaldehyde for 30 min
at room temperature (RT), permeabilized in 0.5% Triton-X 100
for 20min on ice, blocked with 40% FBS/40% goat serum for 30
min at RT and stained for the viral immediate-early (IE) proteins
1 and 2 (MAb810, 1:600, Light Diagnostics, Temecula, CA).
Nuclei were labeled with Hoechst 33342 (0.2mg/ml; Molecular
Probes, Eugene, OR). Samples were viewed using a Nikon Eclipse
E600 fluorescence microscope equipped with an iVision-Mac
imaging software.
Virus Titrations
Titers of culture supernatants and cell-associated virus, obtained
by sonication of LC pellets for ∼1 s with a Branson Ultrasonics
Sonifier 150, were determined by staining HFF with MAb810 at
24 h post-infection.
Statistical Analysis
Linear regression analyses of data distributions were performed
using Prism 7.0. The cumulative distributions of any two data sets
were compared using the Kolmogorov-Smirnov test. Differences
were considered significant at P < 0.05.
RESULTS
LC Activation Increases the Number of
Infected Cells but Not Viral Yields
Immature LC differentiated from the CD34+ progenitor cells
of different donors were cultured for 2 days in one of
seven activation media, consisting of GM-CSF/FBS, GM-
CSF/CD40L, GM-CSF/LPS, GM-CSF/CD40L/LPS (40LPS), GM-
CSF/FBS/CD40L/LPS (mLC medium; Lauron et al., 2014;
Coronel et al., 2015), interleukin 6 (IL-6), IL-1β, PGE2, and TNF-
α (pro-inflammatory mix, INF) (Jonuleit et al., 1997; Beck et al.,
2003; Sénéchal et al., 2004), or GM-CSF, FBS, CD40L, LPS, IL-
1β, IL-6, PGE2, and TNF-α (mLC and pro-inflammatory mix
combination, mINF). Cells were then infected with CMV strain
TB40/E at a calculated MOI of 10, and the proportion of cells
expressing the viral immediate-early (IE) proteins 1 and 2 at day
2, 4, 6, 8, and 10 was determined.While culture in CD40L, 40LPS,
mLC, INF, and mINF conditions increased the total number
FIGURE 1 | Activation differentially affects the number of IE+ cells and
progeny yields. LC cultured under eight different conditions were infected
with TB40/E at an MOI of 10, and subsequently maintained in each medium for
10 days, with cell and supernatant collections every 2 days. The total number
of IE+ cells present in each well was determined by immunofluorescence
staining analyses (A), the amount of virus present in each supernatant was
assessed by titration (B) and the total number of cells per well was counted
(C). The median number of cells expressing the IE proteins at day 2 was then
plotted against the median number of plaque forming units (pfu) present in the
supernatants collected from each well at days 6–10 (D), and the best-fitting
line modeling the relationship between the X and Y values of all data points
except those of mLC cultures was identified by linear regression (Y = 0.7X, R2
= 0.87). Symbols represent the median and median absolute deviation values
of data collected with LC derived from six different CD34+ cell donors in eight
independent experiments, from three donors in two independent experiments
(C) and from three donors in two independent experiments (40LPS condition).
of infected cells by ∼3-fold at early times as compared to iLC,
exposure to FBS or LPS had no boosting effects (Figure 1A). The
CD40L, 40LPS, mLC, INF, and mINF data distributions were
also significantly different from that of iLC according to two
sample, unpaired Kolmogorov-Smirnov (KS) tests (P-value for
each comparison<0.0001), while those of FBS and LPS were not.
Importantly, none of these conditions increased the proportion
of infected cells to 100%, as observed in high MOI infections of
fully susceptible cells. This suggests that only a specific subset of
LC is permissive to CMV infection, and that this subset can only
be slightly expanded by cell activation.
Consistent with our previous findings using CMV strain
TB40-BAC4 and AD169varATCC (Coronel et al., 2015),
infection of iLC with TB40/E was productive (Figure 1B).
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Progeny was also made by activated cells, with CD40L, 40LPS,
INF, and mINF cultures producing similar amounts of virus as
iLC at peak times, FBS and LPS populations producing ∼2-fold
less, and mLC ∼10-fold less. The kinetics of viral replication
in INF and mINF treated cells were also slightly different from
the rest, as yields started to rise from day 4 instead of from day
6 (Figure 1B). Only the mLC data distribution, however, was
significantly different from that of iLC according to KS tests (P
< 0.0007). Finally and importantly, these differences were not
due to extensive cell death affecting some conditions (e.g., mLC)
more than others, as the number of cells per well did not display
dramatic variations among cultures (Figure 1C).
The Number of Infected Cells Present at
Infection Onset Is Predictive of the
Magnitude of Progeny Production
The number of CMV particles produced at peak times upon high
MOI infection of permissive cells is usually directly proportional
to the initial amount of infected cells (Coronel et al., 2015). To
assess if this was also true for LC cultures, the median number
of particles per well present at day 6–10 was plotted against the
median number of IE+ cells detected at day 2 (Figure 1D). A
linear relationship was observed between these two parameters
for most conditions (Y = 0.7X, R2 = 0.87), whereby for each
new IE+ cell gained at day 2, the median number of particles
per well is increased by 0.7 units. Importantly, data from 40LPS
and mLC cultures did not fit with this equation, displaying yields
per cell 2-fold (40LPS) and 11-fold (mLC) lower than expected
(Figure 1D).
Populations Containing Large Amounts of
Infected Cells Are Not the Most Efficient at
Producing Progeny
Although the extent of IE protein expression was enhanced
and prolonged in CD40L, 40LPS, INF, and mINF conditions
(Figure 1A), yields failed to increase proportionally (Figure 1B).
Consequently, none of the tested treatments improved the
efficiency of progeny production of iLC cultures (Figure 2A).
Rather, exposure to LPS, 40LPS, mLC, and INF significantly
worsened it (Figure 2B).
Interestingly, an inverse correlation was also observed
between the median number of IE+ cells present in each well
at day 6–10 and the median number of particles produced by
each IE+ during the same period of time, suggesting that the
efficiency of progeny production decreases when the number of
infected cells increases (Figure 2C). Data distributions could be
modeled by the best fit linear equation Y = −0.0002X + 3.3
(R2 = 0.92), according to which acquisition of a new IE+ cell
reduces the efficiency of progeny production by ∼0.0002 pfu.
Mature LC populations represented, once again, an exception to
this rule, with yields∼13-fold lower than expected. Interestingly,
LPS-treated cells also appeared to be less efficient than expected:
despite containing roughly the same number of IE+ cells as
iLC, these cultures produced about half as much virus. These
data suggest that conditions which support prolonged IE protein
expression do not concomitantly enhance the ability of infected
FIGURE 2 | Progeny production efficiencies inversely correlate with the
number of infected cells present at late times post-infection. Immature
and activated LC were infected with TB40/E at an MOI of 10, and the amount
of progeny per IE+ cell released in the supernatant during the entire time
course (A) and at peak times (days 6–10, B) was calculated. The median
number of pfu/IE+ cell was then plotted against the median number of cells
expressing the IE proteins in each well at the same time (C). The best-fitting
line modeling the relationship between the X and Y values of all data points
except those of mLC and LPS cultures was identified by linear regression (Y =
–0.0002X + 3.3, R2 = 0.92). Symbols represent the median and median
absolute deviation values of data collected with LC derived from six different
CD34+ cell donors in eight independent experiments, and from three donors
in two independent experiments (40LPS condition). The P-values for pairwise
comparisons of data distributions using the KS test are shown.
cells to produce progeny, possibly due to the presence of one
or more restrictions to viral genome replication or to virion
assembly, maturation, and release.
Loss of Progeny Production Efficiency Is
Not Due to Defects in Particle Release
We previously showed that the intracellular content of viral
genomes from CMV strain AD169varATCC and TB40-BAC4
progressively declined over time in iLC populations, reaching
values 20–25-fold lower than input, while genome loss in
mLC was slower and much less dramatic, halting at values 4–
5-fold lower than input (Coronel et al., 2015). In addition,
the distribution of viral genomes per cell in infected mLC
populations was consistent with the occurrence of viral DNA
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FIGURE 3 | Cell-free and cell-associated progeny yields in infected LC
cultures. Immature and activated LC were infected with TB40/E at an MOI of
10, and the amount of cell-associated virus per IE+ cell present at days 6–10
was calculated (B) and plotted against the amount of cell-free virus per IE+
cell present in each medium during the same time frame (A). The best-fitting
line modeling the relationship between the X and Y values of all data points
was identified by linear regression (Y = 0.5X, R2 = 0.96). Symbols represent
the median and median absolute deviation values of data collected with LC
derived from three different CD34+ cell donors in three independent
experiments, and from three donors in two independent experiments (40LPS
condition). The P-values for pairwise comparisons of data distributions using
the KS test are shown.
replication (Coronel et al., 2015). We thus speculated that the
low efficiency of progeny production of mLC populations could
be due to defects in viral particle production or release, rather
than to impairments in viral genome replication. To test this
hypothesis, the amount of cell-associated virus per IE+ cell
was plotted against the amount of cell-free virus per IE+ cell
present in each culture (Figure 3A). Very interestingly, all LC
populations appeared to release approximately half of the virus
produced (Y = 0.5X, R2 = 0.96), suggesting that the low
yields observed in mLC and in other cultures (Figure 2B) are
unlikely to be due to defects in progeny release. Instead, progeny
production per se may be impaired, as the mLC, LPS, 40LPS,
INF, and mINF data distributions were significantly different
and lower than that of iLC, FBS, and CD40L (Figure 3B). While
this impairment may still be the result of reduced viral genome
replication in LPS, 40LPS, INF, and mINF cultures, a block
in particle maturation is more likely to be the cause in mLC
populations.
CD40L and LPS Exert Opposing Effects on
Infection Progress
Despite containing higher amounts of IE+ cells than iLC cultures
(Figure 1A), mLC yields were dramatically lower (Figure 1B),
likely because of defects in progeny production (Figure 3). While
exposure to CD40L alone increased the number of infected cells
but did not boost yields, exposure to LPS alone did not affect
the number of IE+ cells but reduced progeny amounts relative to
those of iLC. Consequently, the efficiency of progeny production
per cell was high in CD40L cultures, but significantly lower in
LPS-treated cells. The combination of CD40L and LPS led to
additional increases in the number of IE+ cells but not in titers,
causing yields per cell to drop (Figures 2A,B, 3B). This suggests
that CD40L and LPS may exert opposing effects on infection
progress, with CD40L stimulating IE protein expression and
LPS inhibiting progeny production. Neither stimulus, however,
alone or in combination, recapitulated the exact phenotype of
mLC cultures, which appears to require the addition of FBS.
This suggests that the negative effects of LPS, rather than the
positive influence of CD40L, are enhanced by FBS, even though,
when used in isolation, FBS yields per cell are similar to those
of iLC and CD40L populations (Figures 2A,B, 3B). Interestingly,
addition of the mLC cocktail to the IL-6, IL-1β, PGE2, and
TNF-α mix in the mINF samples did not dramatically lower
the efficiency of progeny production, suggesting that signaling
by pro-inflammatory cytokines may partially relieve the block
imposed by the combination of FBS, CD40L, and LPS.
Viral Reactivation Is Not Enhanced by LC
Activation
In directly infected cells, viral replication initiates in the presence
of the tegument proteins, released into the cell upon entry, and
from DNA molecules newly introduced into the nucleus. Viral
reactivation from latently infected cells, by contrast, initiates
from genomes that have been maintained within the cell nucleus
for prolonged periods of time, and in the absence of tegument
proteins.
We thus wondered if the observed effects of cell activation on
lytic replication would also apply to reactivation from latency.
CD34+ cells from the same donors used in lytic infection assays
were exposed to TB40/E virions at a calculated MOI of 10 for
4 h, prior to culture in iLC medium for 8 days. At the end
of the differentiation period, a fraction of latently infected iLC
was plated onto uninfected HFF, and the number of plaques
that developed after 8 days of co-culture was counted. The
remaining iLC were re-plated in either iLC conditions, or in
each medium. Supernatants and cells were then collected at day
2, 4, and 8 (corresponding to day 10, 12, and 16 post CD34+
cells infection), and used in titration assays or in reactivation
experiments, respectively.
Consistent with our previous results using CMV strain
AD169varATCC and TB40-BAC4 (Coronel et al., 2015), IE+
cells were not observed in any culture at any time (not shown),
indicating that TB40/E infection of CD34+ cells was not lytic.
Also in agreement with our previous findings, extremely low
amounts of viral particles were detected in the supernatant of
latently infected iLC and mLC at day 2, 4, and 8 after re-plating.
Similar results were obtained in each condition (Table 1, Pfu),
suggesting that differentiation of latently infected CD34+ cells
into iLC, and their subsequent exposure to activation stimuli,
is not sufficient to trigger robust viral reactivation. By contrast,
∼10-fold higher numbers of plaques per cell were observed
upon co-culture of each LC type with HFF (Table 1, Plaques),
supporting our previous conclusion that additional stimulation
beyond that provided by the activation cocktails, and possibly
consisting of soluble factors secreted by HFF or LC during the
co-culture period, is required to induce full reactivation (Coronel
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TABLE 1 | Viral particle content per 105 cells in the supernatant of cells
differentiated from latently infected CD34+ progenitors (Pfu) and number
of plaques per 105 cells obtained after their co-culture with HFF (Plaques).
Donor 1 Donor 2
Day 2 Day 4 Day 8 Day 2 Day 4 Day 8
iLC pfu 2 2 0 3 1 0
iLC plaques 10 50 10 80 30 10
FBS pfu 1 0 2 6 0 0.5
FBS plaques 40 30 10 10 40 10
CD40L pfu 0 0 0 1 0 0.7
CD40L plaques 10 50 0 10 50 10
LPS pfu 0 1 0 0 0 0
LPS plaques 10 0 0 0 0 10
mLC pfu 2 0 0 0 0 0
mLC plaques 30 10 0 10 0 0
INF pfu 2 0 1 0 2 0
INF plaques 10 60 50 30 50 50
mINF pfu 2 0 1 2 1 0
mINF plaques 10 40 30 30 30 20
et al., 2015). Alternatively, contact with HFF may facilitate the
release of reactivated virus from latently infected LC via enhanced
cell-to-cell transmission.
Plaques were consistently detected in co-culture wells seeded
with iLC harvested at the end of the CD34+ cells differentiation
period (Figure 4A). While the number of reactivation events
produced by iLC populations progressively declined over time, a
drop from day 0 to day 2 was observed in all other conditions.
This was followed by a stabilization at day 4, and by another
decrease to values ∼10-fold lower than those of day 0 in iLC,
FBS, CD40L, LPS, and mLC cultures. Importantly, this decline
in reactivation frequencies was not due to widespread cell death,
as cell numbers increased in all cultures except INF during the
same time frame (Figure 4B). In sharp contrast, the number of
plaques detected in INF and mINF cultures rose from day 2 to
4 and remained high at day 8, ending at values only ∼2-fold
lower than those of day 0. Intriguingly, the median number of
plaques produced by mLC and LPS cultures was lower than that
of iLC, FBS, and CD40L populations (Figure 4C), thus mirroring
the differences observed in lytically infected cultures (Figures 2B,
3B), without however reaching the same degree of statistical
significance. Thus, although the positive or negative influences
exerted by each treatment on viral replication may be similarly
effective during lytic and latent infection, their effects are likely
altered or clouded by the presence of factors secreted during the
co-culture period and/or ensuing LC contact with HFF.
DISCUSSION
Horizontal CMV transmission is thought to occur by contact
between virions and host oronasal mucosae, whose outer layers
are exclusively populated by epithelial cells and LC. These cell
types are thus likely to play important roles in CMV acquisition
and intra- as well as inter-host viral spread.
FIGURE 4 | Efficiency of viral reactivation in latently infected LC
populations. CD34+ cells were exposed to TB40/E virions at a calculated
MOI of 10 for 4 h, washed and cultured in iLC differentiation medium for 8
days. A portion of latently infected iLC harvested at day 8 was then plated
onto uninfected HFF, and the number of plaques that developed during a
period of 8–10 days was counted (day 0). The remaining iLC were re-plated in
either iLC conditions or in each activation medium. Cells were collected at day
2, 4, and 8, counted and co-cultured with uninfected HFF for 8–10 days. The
number of plaques that developed in each condition and at each time post
re-plating (A), the total number of cells per well (B) and the overall median
number of plaques (C) were calculated. Graphs show median and median
absolute deviation values of data collected with latently infected LC derived
from five different CD34+ cell donors in two independent experiments.
Both the phenotype and functions of mucosal LC can
be strongly modulated by contact with soluble factors, other
immune cells, and pathogenic or commensal microorganisms.
LC responses to incoming CMV virions are thus likely to vary
depending on their degree and mode of activation. In this work,
we sought to assess the impact of different activation stimuli on
the ability of in vitro-generated LC to support CMV infection and
reactivation.
Consistent with our previous data (Hertel et al., 2003;
Lauron et al., 2014; Coronel et al., 2015), we found that IE
expression in iLC populations is very limited, and ∼20-fold
lower than what expected for high MOI infections of fully
permissive cells such as HFF (Coronel et al., 2015). These
findings provide further support to our hypothesis that a block
restricting transcription or translation of the UL122/123 genes,
encoding the IE1/IE2 proteins, exists in a large proportion of
iLC cultures (Lauron et al., 2014). The fact that exposure to
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select activation stimuli increases the number of infected cells
(Figure 1) suggests that some signaling pathways can partially
relieve this block.We think that these signals aremost likely to act
directly on viral gene transcription, rather than on virion entry
or intracellular trafficking, as iLC contain more viral particles
than mLC at early times post-infection (Lauron et al., 2014),
similar numbers of viral genomes reach the nucleus of both
cell types (Lauron et al., 2014), and prolonged exposure to the
inoculum does not substantially increase the proportion of IE+
cells (not shown). The antiviral activities of nuclear domain
10 bodies (ND10) are also unlikely to be the main source of
this block, as expression of specific ND10 components such as
PML and hDaxx was increased, rather than reduced, in cells
exposed to IL-6 (Hubackova et al., 2012), IL-1β (Heuser et al.,
1998; Ha et al., 2006), or CD40L (Salomoni et al., 2006). The
enhancement of viral gene transcription ensuing signaling by
activation stimuli may occur, for instance, if the abundance,
availability or activation status of transcription factors such as the
major immediate-early promoter activators NF-kB, CREB, and
Sp1 (Hunninghake et al., 1989; Sambucetti et al., 1989; Lang et al.,
1992) is altered. Alternatively, signaling may affect the degree
of chromatinization of viral genomes, or change their epigenetic
landscape, tilting the balance in favor of transcription activation
by promoting histone acetylation and/or demethylation. Clearly,
additional studies are needed to define the exact mechanisms
acting in each population, keeping in mind that these are likely
to differ, either qualitatively or quantitatively, in cultures exposed
to each activation mix.
Similar to other permissive cells, the viral yields of
each population (with the exception of mLC) were directly
proportional to the amount of infected cells present at infection
onset (Figure 1). The calculated number of particles produced
by each initially infected cell (0.7 pfu/cell), however, remained
substantially lower than that of other cell types (10 or more
pfu/cell; Coronel et al., 2015), and could not be increased by LC
activation. Also in contrast to other cell types, the efficiency of
progeny production per cell was larger in populations containing
smaller number of infected cells (Figure 2). This could be due to
the fact that the initial pool of progeny-producing cells present
in populations with low numbers of IE+ cells such as iLC and
FBS is not expanded by activation, so that each additional IE+
cells contributes little to final yields. Alternatively, activation
may lower the ability of each IE+ cells to produce particles. In
either case, infection progress appears to be restricted in most
activated LC populations. These restrictions did not appear to
affect progeny release (Figure 3A). Rather, activation with most
stimuli led to a sharp decline in the amount of intracellular virus
produced by each IE+ cell, indicating that one or more steps
leading to the production of infectious particles, such as capsid
egress from the nucleus and virion assembly in the cytoplasm,
may be blocked in these cells (Figure 3B).
Mature LC populations were the most severely affected of
all. While containing higher numbers of IE+ cells, total yields
as well as yields per IE+ cell are dramatically reduced. Of the
three components of the mLC cocktail, CD40L appeared to
exert a positive effect on both IE protein expression and yields,
while FBS diminished both, so that the efficiency of progeny
production per cell of both treatments were similar to that of
iLC (Figure 2). LPS, by contrast, had no effect on the number of
infected cells but strongly reduced yields, thus lowering the extent
of particle production per cell (Figure 2). Combined, CD40L, and
LPS increased the number of IE+ cells but not yields, further
reducing the efficiency of progeny production (Figure 2). This
suggests that the mLC phenotype may arise, in part, from the
opposing effects of these two molecules: while CD40L signaling
may stimulate transcription or translation of the IE proteins,
perhaps by acting on the major immediate early genes promoter,
LPS signaling may induce the expression of cellular proteins that
inhibit viral progeny production.
Very interestingly, the iLC, FBS, CD40L, LPS, and mLC
cocktails appeared to have similar effects on viral progeny
production starting from genomes introduced by virions during
lytic infection as well as from latent viral DNA (Figure 4).
This suggests that the restrictions imposed by each stimulus to
viral cycle progression are not strongly affected by the action
of the tegument proteins released during entry, and can affect
progeny production rates independently of the origin of viral
DNA (i.e., whether already present in the nucleus or newly
introduced by virions). This is an interesting finding, considering
that the number and availability of viral genomes should be
higher in directly infected cells. Equally interesting is the fact
that iLC cultures can support viral reactivation to a similar
extent as mature cells. In keeping with our previous results
(Coronel et al., 2015), this suggest that differentiation of latently
infected CD34+ cells into iLC is sufficient to initiate the process
of reactivation without an absolute requirement for activation.
This is in agreement with data from Reeves et al. (Reeves and
Sinclair, 2013), showing that circulating, immature DC express
the UL122/123 transcripts and release low amounts of reactivated
virus upon co-culture with human fibroblasts, but are in contrast
to other reports showing that LPS treatment of circulating DC
(Reeves and Sinclair, 2013) and of monocyte-derived LC (Huang
et al., 2012) enhance the frequency of reactivation events. The
specific reasons for this discrepancy are unclear, but may be
related to the fact that we stimulated iLC with LPS in the presence
of GM-CSF, thus potentially triggering different signaling
pathways.
The only treatment capable of increasing and/or prolonging
the incidence of reactivation above that of iLC was exposure to
pro-inflammatory cytokines. Inflammation has been associated
with increased CMV reactivation rates in immunocompromised
(Fietze et al., 1994; Humar et al., 1999; Reinke et al., 1999)
and immunocompetent but critically ill patients (Limaye and
Boeckh, 2010; Cook and Trgovcich, 2011), and in naturally or
experimentally infected myeloid cells (Stein et al., 1993; Prösch
et al., 1995; Hahn et al., 1998; Hargett and Shenk, 2010; Reeves
and Compton, 2011; Huang et al., 2012; Reeves and Sinclair,
2013). We believe that these stimulatory effects are due to the
up-regulation of UL122/123 genes transcription, as it occurs in
other cell types after treatment with TNF-α, IL-1β, IL-6, and
PGE2 (Stein et al., 1993; Prösch et al., 1995; Kline et al., 1998;
Zhu et al., 2002). To our knowledge, this is the first report
showing a stimulatory effect of these cytokines, combined, on
CMV reactivation from latency.
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